| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,658 |
6,096 |
$232K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,619 |
2,553 |
$206K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,906 |
3,594 |
$195K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,246 |
2,158 |
$171K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
853 |
830 |
$72K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,748 |
4,516 |
$38K |
| S8301 |
Infection control supplies, not otherwise specified |
11,241 |
10,365 |
$38K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
115 |
109 |
$37K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
849 |
798 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,578 |
1,511 |
$21K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,281 |
1,117 |
$18K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,726 |
1,693 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
380 |
374 |
$5K |
| 90837 |
Psychotherapy, 53 minutes with patient |
71 |
25 |
$5K |
| 97802 |
|
379 |
370 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
336 |
324 |
$4K |
| 99072 |
|
7,960 |
7,252 |
$4K |
| 99381 |
|
29 |
28 |
$2K |
| 99215 |
Prolong outpt/office vis |
17 |
16 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
38 |
37 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
39 |
37 |
$898.16 |
| 92551 |
|
157 |
145 |
$754.84 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
12 |
$667.29 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
43 |
38 |
$545.22 |
| 99429 |
|
25 |
25 |
$506.94 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
37 |
37 |
$486.63 |
| 96161 |
|
1,216 |
1,169 |
$406.47 |
| 87807 |
|
30 |
29 |
$314.05 |
| 96160 |
|
871 |
825 |
$152.03 |
| V5008 |
Hearing screening |
99 |
95 |
$70.00 |
| 90686 |
|
426 |
416 |
$19.40 |
| 96127 |
|
3,302 |
3,216 |
$2.70 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
28 |
28 |
$0.30 |
| 90461 |
|
18 |
17 |
$0.30 |
| 90677 |
|
20 |
18 |
$0.03 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
13 |
13 |
$0.02 |
| 91307 |
|
18 |
14 |
$0.01 |
| 90670 |
|
315 |
312 |
$0.01 |
| 90680 |
|
67 |
65 |
$0.00 |
| 90647 |
|
105 |
104 |
$0.00 |
| 90723 |
|
127 |
124 |
$0.00 |
| 90716 |
|
26 |
25 |
$0.00 |
| 3074F |
|
447 |
407 |
$0.00 |
| 3008F |
|
1,116 |
984 |
$0.00 |
| 90697 |
|
14 |
13 |
$0.00 |
| 1125F |
|
42 |
33 |
$0.00 |
| 99173 |
|
85 |
76 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
478 |
463 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
362 |
351 |
$0.00 |
| 3078F |
|
435 |
398 |
$0.00 |
| 90707 |
|
27 |
26 |
$0.00 |
| 1159F |
|
1,079 |
954 |
$0.00 |
| 94664 |
|
37 |
37 |
$0.00 |
| 90633 |
|
13 |
13 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
86 |
80 |
$0.00 |